Table of Contents
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global Hyperhidrosis Treatment Market, by Type
1.1.2. Global Hyperhidrosis Treatment Market, by Treatment
1.1.3. Global Hyperhidrosis Treatment Market, by End User
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.5. Breakdown of Primary Respondents
3.6. Forecasting Techniques
3.7. Research Methodology for Market Size Estimation
3.8. Bottom-Up Approach
3.9. Top-Down Approach
3.10. Data Triangulation
3.11. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.2.1. R&D and Designing
5.2.2. Manufacturing
5.2.3. Distribution & Sales
5.2.4. Post Sales Services
5.3. Pipeline Product Analysis
6. GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY TYPE
6.1. Overview
6.2. Primary Hyperhidrosis
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3. Secondary Generalized Hyperhidrosis
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7. GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT
7.1. Overview
7.2. Botulinum Toxin Injections
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3. Topical Treatment
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.4. Surgical Treatment
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.5. Oral Medication
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.6. Microwave Therapy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.7. Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8. GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY END USER
8.1. Overview
8.2. Dermatology Clinics
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.3. Ambulatory Surgery Centers
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.4. Payers/Patients
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.5. Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
9. GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. UK
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitor Dashboard
10.3. Major Growth Strategy in the Global Hyperhidrosis Treatment Market
10.4. Competitive Benchmarking
10.5. The Leading Player in terms of Number of Developments in the Global Hyperhidrosis Treatment Market
10.6. Key Developments & Growth Strategies
10.7. Major Players Financial Matrix & Market Ratio
11. COMPANY PROFILE
11.1. Allergan PLC
11.1.1. Company Overview
11.1.2. Products/Services Offered
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Brickell Biotech Inc.
11.3. Cynosure
11.4. Dermadry Laboratories lnc.
11.5. Dermira Inc.
11.6. GlaxoSmithKline PLC
11.7. Miramar Labs, Inc.
11.8. Sesderma
11.9. Ulthera Inc.
11.10. Others
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL HYPERHIDROSIS TREATMENT MARKET SYNOPSIS, 2020–2027
TABLE 2 GLOBAL HYPERHIDROSIS TREATMENT MARKET ESTIMATES & FORECAST, 2020–2027 (USD MILLION)
TABLE 3 GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 4 GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)
TABLE 5 GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 6 GLOBAL HYPERHIDROSIS TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 7 NORTH AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 8 NORTH AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)
TABLE 9 NORTH AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 10 US: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 11 US: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)
TABLE 12 US: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 13 CANADA: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 14 CANADA: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)
TABLE 15 CANADA: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 16 LATIN AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 17 LATIN AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)
TABLE 18 LATIN AMERICA: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 19 EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 20 EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)
TABLE 21 EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 25 EASTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 26 EASTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)
TABLE 27 EASTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: HYPERHIDROSIS TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: HYPERHIDROSIS TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: HYPERHIDROSIS TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL HYPERHIDROSIS TREATMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL HYPERHIDROSIS TREATMENT MARKET
FIGURE 4 GLOBAL HYPERHIDROSIS TREATMENT MARKET SHARE, BY TYPE, 2020 (%)
FIGURE 5 GLOBAL HYPERHIDROSIS TREATMENT MARKET SHARE, BY TREATMENT, 2020 (%)
FIGURE 6 GLOBAL HYPERHIDROSIS TREATMENT MARKET SHARE, BY END USER, 2020 (%)
FIGURE 7 GLOBAL HYPERHIDROSIS TREATMENT MARKET SHARE, BY REGION, 2020 (%)
FIGURE 8 AMERICAS: HYPERHIDROSIS TREATMENT MARKET SHARE BY REGION, 2020 (%)
FIGURE 9 NORTH AMERICA: HYPERHIDROSIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 10 EUROPE: HYPERHIDROSIS TREATMENT MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 WESTERN EUROPE: HYPERHIDROSIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 ASIA-PACIFIC: HYPERHIDROSIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 13 MIDDLE EAST & AFRICA: HYPERHIDROSIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 14 GLOBAL HYPERHIDROSIS TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 15 ALLERGAN PLC: KEY FINANCIALS
FIGURE 16 ALLERGAN PLC: SEGMENTAL REVENUE
FIGURE 17 ALLERGAN PLC: REGIONAL REVENUE
FIGURE 18 BRICKELL BIOTECH INC.: KEY FINANCIALS
FIGURE 19 BRICKELL BIOTECH INC.: SEGMENTAL REVENUE
FIGURE 20 BRICKELL BIOTECH INC.: REGIONAL REVENUE
FIGURE 21 CYNOSURE: KEY FINANCIALS
FIGURE 22 CYNOSURE: SEGMENTAL REVENUE
FIGURE 23 CYNOSURE: REGIONAL REVENUE
FIGURE 24 DERMIRA INC.: KEY FINANCIALS
FIGURE 25 DERMIRA INC.: SEGMENTAL REVENUE
FIGURE 26 DERMIRA INC.: REGIONAL REVENUE
FIGURE 27 GLAXOSMITHKLINE PLC: KEY FINANCIALS
FIGURE 28 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE
FIGURE 29 GLAXOSMITHKLINE PLC: REGIONAL REVENUE
FIGURE 30 MIRAMAR LABS, INC.: KEY FINANCIALS
FIGURE 31 MIRAMAR LABS, INC.: SEGMENTAL REVENUE
FIGURE 32 MIRAMAR LABS, INC.: REGIONAL REVENUE
